Drug Type Chemical drugs |
Synonyms 叶酸/胆钙化醇/钴胺素/柠檬酸钙, 칼시큐정 |
Mechanism Folate receptor modulators, MUT stimulants(Methylmalonyl-CoA Mutase stimulants), VDR agonists(Vitamin D receptor agonists) + [1] |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (19 Aug 2024), |
Regulation- |
Molecular FormulaC19H19N7O6 |
InChIKeyOVBPIULPVIDEAO-LBPRGKRZSA-N |
CAS Registry59-30-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Developmental Disabilities | KR | 19 Aug 2024 | |
Rickets | KR | 19 Aug 2024 |